IP Library Granted Patent US 11,179,505
Granted Patent B2
US 11,179,505 · App. 16/077,143 · Granted Nov 23, 2021

Methods for stabilizing collagen-containing tissue products against enzymatic degradation

Inventors: Israel Jessop (Annandale, NJ); Ming F. Pomerleau (Califon, NJ); Nathaniel Bachrach (Clifton, NJ)
Assignee: LifeCell Corporation
A61L31/044A61F2/0063A61L31/005A61F2002/0068A61L2430/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,179,505
App. No.
16/077,143
Granted
Nov 23, 2021
Kind
B2
Abstract

Methods for producing crosslinked tissue matrices, crosslinked tissue matrices produced by such methods, as well as tissue products comprising such tissue matrices are disclosed. The methods comprise (1) dehydrating a collagen-containing tissue matrix to form a dehydrated collagen-containing tissue matrix; and (2) irradiating the dehydrated collagen-containing tissue matrix such that at least a portion of the dehydrated collagen-containing tissue matrix is crosslinked.

Claims (12)

1. A method for producing a crosslinked tissue matrix, comprising:

(1) dehydrating a collagen-containing tissue matrix to form a dehydrated collagen-containing tissue matrix, wherein the collagen-containing tissue matrix is a dermal tissue matrix and has a thickness of greater than 200 μm; followed by

(2) irradiating the dehydrated collagen-containing tissue matrix with UV light such that at least a portion of the dehydrated collagen-containing tissue matrix is crosslinked and such that the crosslinked tissue matrix is free of cytotoxic residues.

2. The method of claim 1 , wherein, prior to step (1), the collagen-containing tissue matrix is impregnated with a photo-activated crosslinker and wherein the photo-activated crosslinker is riboflavin-5′-phosphate.

3. The method of claim 1 , wherein the collagen-containing tissue matrix is impregnated with riboflavin-5′-phosphate by soaking it in an aqueous solution comprising riboflavin-5′-phosphate.

4. The method of claim 3 , wherein the aqueous solution comprises from 0.1 to 1.0% by weight of riboflavin-5′-phosphate and wherein the aqueous solution is a phosphate-buffered saline solution.

5. The method of claim 1 , wherein the UV light is UV-A light that has a wavelength of 370 nm.

6. The method of claim 1 , wherein the collagen-containing tissue matrix is dehydrated via vacuum drying, air drying, or treatment with an inert gas.

7. The method of claim 1 , further comprising:

(3) rehydrating the crosslinked collagen-containing tissue matrix.

8. The method of claim 1 , wherein the entire dehydrated collagen-containing tissue matrix is irradiated with UV light; or wherein one or more select regions of the collagen-containing tissue matrix is irradiated with UV light; or wherein an array of lines and/or spots on the collagen-containing tissue matrix is irradiated with UV light through a mask.

9. The method of claim 1 , wherein the collagen-containing tissue matrix is irradiated with UV light such that a pattern of cross-linked collagen-containing tissue matrix is obtained.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2019
From: JESSOP, ISRAEL; POMERLEAU, MING F.; BACHRACH, NATHANIEL
To: LIFECELL CORPORATION
Reel/Frame 050147/0335 →